BridgeBio is significantly improved its progress of the new treatment for ATTR-CM, employing the compound. Preliminary trial results reveals significant outcomes for individuals affected by this serious condition. This https://biotech896385.blogzag.com/85501602/company-progresses-attr-cm-treatment-through-the-drug